win 18446 has been researched along with Ovarian Neoplasms in 1 studies
*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchman, CD; Buckanovich, RJ; Chtcherbinine, M; Debnath, B; Felton, J; Grimley, E; Huddle, BC; Hurley, TD; Larsen, SD; Li, S; Mehta, G; Mehta, P; Morgan, CA; Neamati, N; Sun, D; Yang, K | 1 |
1 other study(ies) available for win 18446 and Ovarian Neoplasms
| Article | Year |
|---|---|
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Agents; Cell Proliferation; Drug Discovery; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Female; Humans; Mice; Neoplastic Stem Cells; Ovarian Neoplasms; Retinal Dehydrogenase; Structure-Activity Relationship; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |